Deoxyspergualin: phase I clinical, immunologic and pharmacokinetic study.
Havlin KA, Kuhn JG, Koeller J, Boldt DH, Craig JB, Brown TD, Weiss GR, Cagnola J, Phillips J, Harman G, et al.
Havlin KA, et al. Among authors: brown td.
Anticancer Drugs. 1995 Apr;6(2):229-36.
Anticancer Drugs. 1995.
PMID: 7795272
Clinical Trial.